We tried, at first, to shake the uncanniness of it all.

After a yearlong wait, vaccines for COVID-19 finally are available, and most Americans’ biggest concern right now is getting vaccinated as quickly as they can.

After more than a dozen countries paused the use of AstraZeneca's coronavirus vaccine due to concerns about blood clots, the European Medicines Agency concluded on Thursday that the vaccine doesn't increase the risk of clotting.

I’m sure you've seen it, pictures and videos on social media of COVID-19 vaccination cards and injections.

With clinical trials planned or underway, children might be able to start receiving COVID-19 vaccines by this fall.

The Food and Drug Administration issued an emergency use authorization for the Johnson & Johnson vaccine last week, with health experts telling Newsweek that its approval could enable the United States to achieve herd immunity by early summer.

When vaccine availability was first announced in December of last year, Renee Michelet Casbergue, PhD, a 66-year old Louisiana resident and retired professor of Louisiana State University, was excited at the prospect of getting vaccinated along with her 98-year-old mother-in-law, Sylvia Casbergue. Like many others in the U.S., they were eager to secure their best shot at protection against COVID-19.

How effective is AstraZeneca's coronavirus vaccine? We still don't have a clear, consistent answer.